Roberto A. Mignone - 05 Jun 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Director
Issuer ticker: TEVA
Reported as of: 05 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 16:02:38 UTC
Prior SEC filing: 01 Jun 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Roberto Mignone

Key filing fact

Roberto A. Mignone filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 08 Jun 2026.

Key facts

This page summarizes Roberto A. Mignone's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2026, 16:02.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258394 Primary reporting owner

MIGNONE ROBERTO

Relationship: Director
Address: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL
Signature: /s/ Dov Bergwerk as attorney-in-fact for Roberto Mignone
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +14,492
Change %: +14%
Price
Shares after: 119,807
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1, F2

TEVA holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 367,600
Date: 05 Jun 2026
Ownership: [see footnote]
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
Shares: -14,492
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 14,492
Exercise price
Footnotes: F1, F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F3

The 367,600 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the "Fund"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose.

Footnote F4

Restricted share units were granted on June 5, 2025 and vested on June 5, 2026.